XML 34 R23.htm IDEA: XBRL DOCUMENT

SHAREHOLDERS' EQUITY (Tables)

6 Months Ended

Feb. 29, 2024

Shares Outstanding

Shares of Company's common stock outstanding for the three and six months ended February 29, 2024 and February 28, 2023 were as follows:



	Three Months Ended February 29,		Six Months Ended February 29,
(in thousands)	February 29, 2024	February 28, 2023	February 29, 2024	February 28, 2023
Common stock outstanding, beginning of period	19,966	20,314	19,938	20,260
Common stock repurchased during the period	—	(409)	—	(409)
Common stock issued during the period	18	26	46	79
Common stock outstanding, end of period	19,984	19,931	19,984	19,931

Schedule of Dividends Payable

The Company’s Board of Directors declared cash dividends during the six months ended February 29, 2024 and fiscal year 2023. The details of dividends paid are in the following tables:


(in thousands, except dividend per share)	Six Months Ended February 29, 2024

Record Date	Distribution Date	Number of Shares Outstanding on Record Date	Dividend per Share		Total Amount
10/30/2023	11/06/2023	19,939	$	0.06	$	1,196
1/29/2024	2/05/2024	19,973	$	0.06	1,198


Total					$	2,394


(in thousands, except dividend per share)	Fiscal Year 2023

Record Date	Distribution Date	Number of Shares Outstanding on Record Date	Dividend per Share		Total Amount
10/31/2022	11/07/2022	20,299	$	0.06	$	1,218
1/30/2023	2/06/2023	19,924	$	0.06	1,195
4/24/2023	5/01/2023	19,999	$	0.06	1,200
7/31/2023	8/07/2023	19,931	$	0.06	1,196
Total					$	4,809

Share-based Payment Arrangement, Option, Activity

The following table summarizes information about stock options:


(in thousands, except per share and weighted-average amounts)
Activity for the six months ended February 29, 2024	Number of Options	Weighted-Average Exercise Price Per Share		Weighted-Average Remaining Contractual Life
Outstanding, August 31, 2023	1,478	$	34.62	6.62 years
Granted	515	40.34
Exercised	(49)	14.47
Canceled/Forfeited	(11)	45.38
Outstanding, February 29, 2024	1,933	$	36.58	7.13 years
Vested and Exercisable, February 29, 2024	861	$	29.14	4.95 years
Vested and Expected to Vest, February 29, 2024	1,852	$	36.40	7.02 years

Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

The following table summarizes the fair value of the options, including both ISOs and NQSOs, granted during the six-month period ended February 29, 2024 and fiscal year 2023:


(in thousands, except weighted-average amounts)	Six Months Ended February 29, 2024			Fiscal Year 2023
Estimated fair value of awards granted	$	10,256		$	10,067
Unvested Forfeiture Rate	6.38		%	0.22		%
Weighted-average grant price	$	40.34		$	43.78
Weighted-average market price	$	40.34		$	43.78
Weighted-average volatility	44.70		%	46.14		%
Weighted-average risk-free rate	4.86		%	4.29		%
Weighted-average dividend yield	0.60		%	0.55		%
Weighted-average expected life	6.59 years			6.55 years

Share-based Payment Arrangement, Option, Exercise Price Range

The exercise prices for the options outstanding at February 29, 2024, ranged from $6.85 to $66.14, and the information relating to these options are as follows:

(in thousands except prices and weighted-average amounts)


Exercise Price				Awards Outstanding				Awards Exercisable
Low		High		Quantity	Weighted -Average Remaining Contractual Life	Weighted-Average Exercise Price		Quantity	Weighted-Average Remaining Contractual Life	Weighted-Average Exercise Price
$	6.85	$	9.77	180	1.56 years	$	8.88	180	1.56 years	$	8.88
$	9.78	$	18.76	146	2.99 years	$	10.08	146	2.99 years	$	10.08
$	18.77	$	33.40	182	5.16 years	$	25.72	163	5.09 years	$	25.01
$	33.41	$	47.63	1,154	8.84 years	$	41.34	213	7.66 years	$	40.92
$	47.64	$	66.14	271	7.07 years	$	56.32	159	6.80 years	$	57.87
				1,933	7.13 years	$	36.58	861	4.95 years	$	29.14